By John Vandermosten, CFA NASDAQ:GRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) reported fiscal year (FY) third quarter results following a series of announcements regarding conference participation, the raise of additional capital and results from the Phase III STRIVE-ON trial for GTx-104. The most important information was the data from the Phase … Read more
The French presidency on Tuesday, November 26, issued a categorical denial that President Emmanuel Macron had predicted that the government of Prime Minister Michel Barnier would soon fall due to a motion of no confidence backed by the far right. The presidency used its official account on X, @Elysée, to deny the story published in … Read more
Question: We recently received a discrimination and harassment claim from a former employee who quit his job. This is the first we’ve heard about these issues; they were never reported to HR. We can’t be liable for claims that were never reported, right? Answer: Wrong, you could … Read more
